close
 |
Clear My Agenda & Abstract Book |
Print My Agenda |
Print My Abstract Book
Download My Agenda in PDF | Download My Agenda in iCal
Download My Agenda in PDF | Download My Agenda in iCal
HPV 2010 Programme
>> Poster Viewing - Epidemiology and Public Health
| Description | Room |
|
|||
|---|---|---|---|---|---|
| L |
P-905: Bacterial vaginosis is associated with cervical human papillomavirus infection: a meta-analysis of published studies
|
|
Add to my agenda | ||
| L |
P-906: Association between bacterial vaginosis and cervical intraepithelial lesion: a systematic review and meta-analysis of published literature
|
|
Add to my agenda | ||
| L |
P-798: Age-specific High risk genotype distribution in a French ASCUS plus cohort population
|
|
Add to my agenda | ||
| L |
P-799: HPV genotypes discrimination by sequencing
|
|
Add to my agenda | ||
| L |
P-801: HPV-16 viral load and its association with cervical abnormalities in a sample of HIV-positive and HIV-negative women in Senegal
|
|
Add to my agenda | ||
| L |
P-800: Predictors of invasive cervical cancer in women below 40 years in a screen and treat'' program in Zambia."
|
|
Add to my agenda | ||
| L |
P-797: Epidemiological profile DNA HPV16 positive women
|
|
Add to my agenda | ||
| L |
P-794: Risk factors for Head and Neck Cancer: Is there a difference by HPV status?
|
|
Add to my agenda | ||
| L |
P-795: Seroprevalence and Determinants of Human Papillomavirus 16/18 Seropositivity among Young Women in Costa Rica
|
|
Add to my agenda | ||
| L |
P-796: Cigarette Smoking, an Independent Risk Factor for HPV Infection and for HSIL?
|
|
Add to my agenda | ||
| L |
P-802: HPV types among HIV positive and negative women with biopsy proven LSIL and HSIL in Senegal, West Africa
|
|
Add to my agenda | ||
| L |
P-808: Worldwide incidence of human papillomavirus infection in women: systematic review and meta-analysis.
|
|
Add to my agenda | ||
| L |
P-809: Prevalence of Oncogenic Human Papillomavirus (HPV) cervical infection in Canada: A systematic review
|
|
Add to my agenda | ||
| L |
P-810: Prevalence of HPV in archived cervical cancer specimens from Alaska Native women, 1980-2007
|
|
Add to my agenda | ||
| L |
P-807: HPV persistence in Guanacaste, Costa Rica: Single- vs. multiple-type prevalent infections
|
|
Add to my agenda | ||
| L |
P-803: Prevalence of HPV types in cancers in the United States 2000-2005
|
|
Add to my agenda | ||
| L |
P-804: A cross sectional study of oral HPV infection in older HIV positive subjects
|
|
Add to my agenda | ||
| L |
P-806: The Cost-Effectiveness of HPV 16/18 Vaccination and Cervical Cancer Screening in Eastern Africa
|
|
Add to my agenda | ||
| L |
P-805: High Prevalence of Carcinogenic HPV Among Older Women in Nigeria, Africa: Can We Still Screen with HPV Testing?
|
|
Add to my agenda | ||
| L |
P-793: HPV - Type-specific distribution in a group of women attending Hospital Fernando Fonseca, Lisbon
|
|
Add to my agenda | ||
| L |
P-780: The influence of pregnancy on hr-HPV detection
|
|
Add to my agenda | ||
| L |
P-781: HPV infection in a clinic-based sample of HIV positive women in Puerto Rico
|
|
Add to my agenda | ||
| L |
P-782: Using catalytic models to investigate trends in HPV seroprevalence by age in the UK
|
|
Add to my agenda | ||
| L |
P-779: Human papillomavirus infection in Algiers, Algeria : a population-based study
|
|
Add to my agenda | ||
| L |
P-776: Prevalence and genetic variability of human papillomavirus 58 in a group of Mexican women with cervical cancer and precursor lesions
|
|
Add to my agenda | ||
| L |
P-777: A bibliometric analysis of prevalence and control of Human Papillomavirus infection among females in the Middle-East
|
|
Add to my agenda | ||
| L |
P-778: Burden of HPV related gynaecological pre-invasive neoplasia and cancer: a population-based study
|
|
Add to my agenda | ||
| L |
P-783: Modelling the cost borderline and mild dysplasia associated with HPV 6 and 11 infection
|
|
Add to my agenda | ||
| L |
P-789: Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan
|
|
Add to my agenda | ||
| L |
P-790: Acceptability of human papillomavirus vaccination among men who have sex with men in Vancouver, Canada
|
|
Add to my agenda | ||
| L |
P-792: Prevalence of genital HPV infection in a population-based pilot study in women living in Canada.
|
|
Add to my agenda | ||
| L |
P-791: Prevalence of rectal human papillomavirus infection in men who have sex with men in Vancouver, Canada
|
|
Add to my agenda | ||
| L |
P-788: Comparison of HPV type distribution and type specific viral load in low and high-grade cervical lesions and cervical cancer
|
|
Add to my agenda | ||
| L |
P-785: Health and economic burden of human papillomavirus-related diseases in singapore
|
|
Add to my agenda | ||
| L |
P-784: Cost-Effectiveness of adding a Quadrivalent Human Papillomavirus (HPV) Vaccine to the Cervical Cancer Screening Program in Singapore
|
|
Add to my agenda | ||
| L |
P-786: Type-Specific HPV Infection among Guatemalan and Honduran women screened by cytology
|
|
Add to my agenda | ||
| L |
P-787: HPV type distribution in invasive cervical cancer and high grade cervical lesions in Singapore
|
|
Add to my agenda | ||
| L |
P-811: Monitoring the impact of HPV16/18 vaccination in a cohort of adolescent girls: Incidence of HPV infections prior to vaccination
|
|
Add to my agenda | ||
| L |
P-837: False-positive Human Papillomavirus tests in cervical screening
|
|
Add to my agenda | ||
| L |
P-838: HPV Vaccine Recommendations: A Case Study in Policy Development for a Global Health Public Health Degree Program
|
|
Add to my agenda | ||
| L |
P-839: Process evaluation: the first step towards an HPV vaccination program evaluation in Ontario
|
|
Add to my agenda | ||
| L |
P-836: Comparison of Surveillance Strategies to Monitor the Impact of HPV Vaccination on Cervical Dysplasia in California
|
|
Add to my agenda | ||
| L |
P-832: Incidence of cervical cancer precursors and clinical burden associated with screening: baseline evaluation before HPV vaccination in Quebec (Canada).
|
|
Add to my agenda | ||
| L |
P-833: Feasibility of unsupervised self-sampling for population-based HPV prevalence studies.
|
|
Add to my agenda | ||
| L |
P-835: India demonstration projects: experiences of reaching adolescent girls with human papillomavirus (HPV) vaccination
|
|
Add to my agenda | ||
| L |
P-834: High-throughput assessment of the prevalence of HPV types before implementation of an HPV vaccination program
|
|
Add to my agenda | ||
| L |
P-840: First year results from an integrated system of public health monitoring of HPV immunisation in Scotland
|
|
Add to my agenda | ||
| L |
P-846: Performance variation but few missed severe lesions in the Finnish cervical cancer screening programme
|
|
Add to my agenda | ||
| L |
P-847: The effect of continuous systematic sex education program on sexually transmitted infections including condyloma acuminatum : an evaluation in Yamagat
|
|
Add to my agenda | ||
| L |
P-848: Prognosis of Human Papillomavirus (HPV)-Positive versus HPV-Negative Head and Neck Cancers: A Systematic Literature Review
|
|
Add to my agenda | ||
| L |
P-845: HPV TESTING IN PRIMARY SCREENING AND TRIAGE OF AS-CUS
|
|
Add to my agenda | ||
| L |
P-841: HPV-genotypes in an asymptomatic Italian population of 1,709 females and males
|
|
Add to my agenda | ||
| L |
P-842: Implementation of Cervical Cancer Screening with HPV testing in Colombia
|
|
Add to my agenda | ||
| L |
P-844: Coverage and compliance of human papillomavirus vaccines in paris: analysis of social security reimbursements.
|
|
Add to my agenda | ||
| L |
P-843: Using evidence for an extended HPV immunization schedule in pre-adolescent girls
|
|
Add to my agenda | ||
| L |
P-831: Cervical cancer prevention in China
|
|
Add to my agenda | ||
| L |
P-818: HPV Type Replacement: An unlikely phenomenon
|
|
Add to my agenda | ||
| L |
P-819: HPV 16,18 vaccination of girls in GAVI-eligible countries: What is the consequence of a delay?
|
|
Add to my agenda | ||
| L |
P-820: Economic evaluation of LBC, AutoLBC and HPV triage testing for cervical screening in Australia
|
|
Add to my agenda | ||
| L |
P-816: Human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia
|
|
Add to my agenda | ||
| L |
P-812: Impact of HPV-Related External Genital Lesions on Quality of Life
|
|
Add to my agenda | ||
| L |
P-813: Impact of HPV-Related, Non-Cancerous and Pre-Cancerous Genital Disease on Psycho-Social Factors and Sexuality
|
|
Add to my agenda | ||
| L |
P-815: Organized vaginal HPV screening program for eldly women in Taiwan
|
|
Add to my agenda | ||
| L |
P-814: Prevalence of multiple anal HR_HPV infections inf HIV-Positive MSM from a cohort study in Spain
|
|
Add to my agenda | ||
| L |
P-821: Time-varying impact of HPV vaccination on the national cervical screening program in New Zealand
|
|
Add to my agenda | ||
| L |
P-828: The basic reproduction number for HPV 6, 11, 16, and 18 infections
|
|
Add to my agenda | ||
| L |
P-829: Why HPV test of cure both saves money and achieves better outcomes
|
|
Add to my agenda | ||
| L |
P-830: A continuous state natural history model and a transmission model with evolving sexual activity
|
|
Add to my agenda | ||
| L |
P-827: Impact of vaccinating boys and men against HPV in the united states
|
|
Add to my agenda | ||
| L |
P-822: HLA-E and HLA-G polymorphisms and risk of high-grade cervical intraepithelial neoplasia and cervical cancer
|
|
Add to my agenda | ||
| L |
P-823: The role of IGF-1 and IGFBP-3 in the development of cervical squamous intraepithelial lesions
|
|
Add to my agenda | ||
| L |
P-825: Modeling an optimal programme of immunization and screening to reduce the lifetime risk of cervical cancer in Japanese women
|
|
Add to my agenda | ||
| L |
P-824: Impact of HPV vaccination on mortality due to cervical cancer in the UK
|
|
Add to my agenda | ||
| L |
P-775: epidemiology of 35 papillomavirus human beings in the cervical samples at the French women treated in hospital of Lyon
|
|
Add to my agenda | ||
| L |
P-723: Attitudes Toward HPV Vaccination Among Females Ages 27 to 45
|
|
Add to my agenda | ||
| L |
P-724: Physicians' Attitudes and Perceptions of HPV Vaccination for Males
|
|
Add to my agenda | ||
| L |
P-725: Strengthening capacities of health professionals to fight against cervical cancer and HPV infection.
|
|
Add to my agenda | ||
| L |
P-722: A multi-center survey on age of sexual debut in Chinese women: suggestions for optimal age of HPV vaccination in China
|
|
Add to my agenda | ||
| L |
P-719: Acceptability and willingness to pay for human papillomavirus vaccine in Vietnam
|
|
Add to my agenda | ||
| L |
P-720: Developmental strategies for a targeted, multimedia intervention to enhance HPV vaccination in a southern U.S. city
|
|
Add to my agenda | ||
| L |
P-721: Mother may I? Attitudes surrounding HPV vaccination from African-American mothers living in the southeastern US
|
|
Add to my agenda | ||
| L |
P-726: What do young women know, think and do about HPV prevention in Québec (Canada)?
|
|
Add to my agenda | ||
| L |
P-732: HPV Vaccine Intent and Uptake in Female Students Accessing Care at a College-Based Gynecology Clinic
|
|
Add to my agenda | ||
| L |
P-733: Factors differentiating high HPV vaccine acceptability from low acceptability among a national sample of adult women
|
|
Add to my agenda | ||
| L |
P-734: Human papillomavirus vaccine preference and intention to vaccinate boys among providers in the Indian Health Service
|
|
Add to my agenda | ||
| L |
P-731: Prevalence of HPV vaccine recommendation among a national sample of U.S. primary care physicians
|
|
Add to my agenda | ||
| L |
P-728: Formative Research in Cervical Cancer Prevention and HPV Vaccine Acceptance in Orissa, India
|
|
Add to my agenda | ||
| L |
P-727: Attitudes of Australian gynaecologists to HPV vaccination
|
|
Add to my agenda | ||
| L |
P-729: The Domino Effect: Adolescent girls' experience of HPV vaccination
|
|
Add to my agenda | ||
| L |
P-730: Impact of genital warts on health related quality of life: a multi-centre hospital-based study in China
|
|
Add to my agenda | ||
| L |
P-718: Reasons for HPV Vaccine Non-Compliance in Women 18-26
|
|
Add to my agenda | ||
| L |
P-705: "Sexuall responsible behavior among adolescents-project-Knowledge is pleasure"
|
|
Add to my agenda | ||
| L |
P-706: The double burden of HPV positivity in Chinese women with borderline abnormal cervical cytology
|
|
Add to my agenda | ||
| L |
P-707: Acceptability of vaginal self-sampling for human papilloma virus among women not attending PAP screening program in CHile."
|
|
Add to my agenda | ||
| L |
P-704: Psychosocial burden of HPV-related lesions among patients in mainland China
|
|
Add to my agenda | ||
| L |
P-700: Acceptability of self collection for human papillomavirus (HPV) in Uganda: The ASPIRE Program
|
|
Add to my agenda | ||
| L |
P-701: HPV detection by self-sampling in Nunavik, Québec: comparability and preference to provider-sampling
|
|
Add to my agenda | ||
| L |
P-703: Multi-center Study on Human Papillomavirus Related Disease in Japan (J-HERS)
|
|
Add to my agenda | ||
| L |
P-708: Predictors of high anxiety following an abnormal cervical cytology result
|
|
Add to my agenda | ||
| L |
P-714: Persuading parents to talk to a doctor about vaccinating their sons and daughters against the human papillomavirus
|
|
Add to my agenda | ||
| L |
P-715: Undergraduate males' HPV vaccination intentions: Theory and beyond
|
|
Add to my agenda | ||
| L |
P-717: Knowledge, attitude and beliefs in cervical cancer prevention and HPV vaccination among college youths in Taiwan - a gender-based approach
|
|
Add to my agenda | ||
| L |
P-716: knowledge, attitudes, and practice of hpv vaccination among ob-gyn physicians in lebanon
|
|
Add to my agenda | ||
| L |
P-713: HPV Vaccine Acceptance among Women in Germany
|
|
Add to my agenda | ||
| L |
P-710: Canadian paediatricians' knowledge and attitudes regarding HPV vaccination: what has changed since program implementation?
|
|
Add to my agenda | ||
| L |
P-709: Disparities in Gardasil uptake in Manitoba, Canada prior to the implementation of an immunization program
|
|
Add to my agenda | ||
| L |
P-711: Does hypothetical HPV vaccine acceptance translate into actual acceptance? The experience of Uganda
|
|
Add to my agenda | ||
| L |
P-712: Delivery strategies for human papillomavirus (HPV) vaccinations that achieve high coverage in developing countries
|
|
Add to my agenda | ||
| L |
P-735: Postapproval HPV vaccine uptake higher than expected in pediatric cohort with minorities having higher vaccination rates than whites
|
|
Add to my agenda | ||
| L |
P-761: HPV DNA and mRNA type distribution in South-Western French women treated for CIN and cancer
|
|
Add to my agenda | ||
| L |
P-762: Human papillomavirus type-16 variants in Spanish women with high grade cervical lesions
|
|
Add to my agenda | ||
| L |
P-763: Genotype distribution of HPV and correlation with cytological data in a region of Spain (Madrid)
|
|
Add to my agenda | ||
| L |
P-760: THE IMPORTANCE OF TYPE-SPECIFIC LOW-RISK HPV INFECTION IN MORE THAN 40 000 DANISH WOMEN FROM THE GENERAL POPULATION
|
|
Add to my agenda | ||
| L |
P-757: Prevalence of Human Papillomavirus Infection and Genotypes in Women Attending Cervical Cancer Screening in Spain
|
|
Add to my agenda | ||
| L |
P-758: HPV genotype prevalence in Australian women pre-vaccination
|
|
Add to my agenda | ||
| L |
P-759: Type-specific oncogenic HPV and Pap findings in Inuit and non-Aboriginal women in Nunavut, Canada
|
|
Add to my agenda | ||
| L |
P-764: Risk of High-Grade Squamous Intraepithelial Lesion (HGSIL) and HLA-C allelic groups
|
|
Add to my agenda | ||
| L |
P-770: Human papillomavirus genotype distribution in oral cavity and oropharynx cancer in France (EDiTH VI)
|
|
Add to my agenda | ||
| L |
P-771: Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Fiji
|
|
Add to my agenda | ||
| L |
P-773: prevalence and associated factors to HPV16&18 in Fianarantsoa Madagscar
|
|
Add to my agenda | ||
| L |
P-772: Epidemiology of HPV infection and cervical cancer in Azores - Portugal.
|
|
Add to my agenda | ||
| L |
P-769: Persistence, acquisition and clearance of HPV DNA in penile in HIV positive men
|
|
Add to my agenda | ||
| L |
P-766: HUMAN PAPILLOMAVIRUS TYPE DISTRIBUTION IN CERVICAL NEOPLASIA: RESULTS FROM TWO PARALLEL EPIDEMIOLOGICAL STUDIES IN WOMEN WITH HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA AND INVASIVE CERVICAL CANCER IN EUROPE
|
|
Add to my agenda | ||
| L |
P-765: HPV DNA genotyping vs. citology in a population of 50.000 women as a part of cervical cancer prevention program.
|
|
Add to my agenda | ||
| L |
P-767: Group-specific HPV concordance among steady couples in Kigali, Rwanda
|
|
Add to my agenda | ||
| L |
P-768: Age-Specific Human Papillomavirus Antibody Prevalence: A Global Review
|
|
Add to my agenda | ||
| L |
P-756: A discrete event simulation approach in modeling the impact of HPV vaccination and cervical cancer screening
|
|
Add to my agenda | ||
| L |
P-742: Survey of women aged 18 to 50 in three European countries: sociodemographic data and sexual behaviour
|
|
Add to my agenda | ||
| L |
P-743: A Strategy to Prevent Cervical Cancer in Latin America and the Caribbean
|
|
Add to my agenda | ||
| L |
P-745: Health and Economic Consequences of Male HPV vaccination on Cervical Cancer Burden in Thailand
|
|
Add to my agenda | ||
| L |
P-740: Attitudes, intentions, and decision-making about HPV vaccination among African American adolescents
|
|
Add to my agenda | ||
| L |
P-737: Ethnic and racial differences in HPV knowledge and vaccine intention among males receiving HPV test results
|
|
Add to my agenda | ||
| L |
P-736: : Oral health providers' knowledge and perceived role regarding prevention of HPV-related oral cancers
|
|
Add to my agenda | ||
| L |
P-738: Factors contributing to uptake of the publicly-funded HPV vaccine among grade 8 females in Toronto.
|
|
Add to my agenda | ||
| L |
P-739: HPV Awareness and HPV Vaccine Awareness and Acceptability in Puerto Rico
|
|
Add to my agenda | ||
| L |
P-746: Cost-Effectiveness of Targeted HPV-16,-18 Vaccination of Men Who Have Sex With Men in the U.S.
|
|
Add to my agenda | ||
| L |
P-752: An evaluation of the estimated health and economic impact of two different HPV vaccines in Canada
|
|
Add to my agenda | ||
| L |
P-753: Cost-effectiveness rapidly declines with increasing age of women targeted for HPV vaccination.
|
|
Add to my agenda | ||
| L |
P-755: COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINATION AND SCREENING IN SPAIN
|
|
Add to my agenda | ||
| L |
P-754: Is switching from repeat cytology to HPV triage a good idea?
|
|
Add to my agenda | ||
| L |
P-751: HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
|
|
Add to my agenda | ||
| L |
P-748: Cost Feasibility Study of Five Cervical Cancer Screening Laboratory Technology Models in Manitoba
|
|
Add to my agenda | ||
| L |
P-747: Low incidence rates of cervical cancer and controversies for cervical cancer prevention in Iran
|
|
Add to my agenda | ||
| L |
P-749: ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN JAPAN USING A TRANSMISSION DYNAMIC MODEL
|
|
Add to my agenda | ||
| L |
P-750: Cost-Effectiveness of Cervical Cancer Prevention Strategies in Thailand
|
|
Add to my agenda | ||
| L |
P-907: Possible relationship between placental Human Papillomavirus infection and spontaneous preterm delivery.
|
|
Add to my agenda | ||
